32 results on '"Zhou, Yinglu"'
Search Results
2. Deciphering the role of KLRB1: a novel prognostic indicator in hepatocellular carcinoma
3. Optimal control strategies and target selection in multi-pursuer multi-evader differential games
4. Five-year follow-up of a phase 2 study of ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial therapy in CLL
5. A phase 1b study of ibrutinib in combination with obinutuzumab in patients with relapsed or refractory chronic lymphocytic leukemia
6. Rewiring of the N-Glycome with prostate cancer progression and therapy resistance
7. Pirtobrutinib targets BTK C481S in ibrutinib-resistant CLL but second-site BTK mutations lead to resistance
8. Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
9. Adaptive Dynamic Programming for a Nonlinear Two‐Player Non‐Zero‐Sum Differential Game With State and Input Constraints.
10. Robust Control for Multiplayer Nonzero‐Sum Differential Games With Switching Topology and Input Delay.
11. Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy
12. Targeting glutamine metabolism network for the treatment of therapy-resistant prostate cancer
13. Functional gradient alteration in individuals with cognitive vulnerability to depression
14. The “Weakest Link” as an Indicator of Cognitive Vulnerability Predicts Stress Generation: A Multi-Wave Longitudinal Study among Adolescents
15. Author Correction: Ectopic JAK–STAT activation enables the transition to a stem-like and multilineage state conferring AR-targeted therapy resistance
16. Optimal pursuit strategies for multi‐pursuer single‐evader games based on cooperative tracking.
17. Oncofetal protein glypican‐3 is a biomarker and critical regulator of function for neuroendocrine cells in prostate cancer.
18. Mental health response for children and adolescents during the COVID-19 outbreak in China
19. A Phase 2 Study of Acalabrutinib, Umbralisib, and Ublituximab (AU2) in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)
20. Erratum to “Pre-existing Castration-resistant Prostate Cancer–like Cells in Primary Prostate Cancer Promote Resistance to Hormonal Therapy” [Eur Urol 2022;81(5):446–55]
21. Resistance to the Non-Covalent BTK Inhibitor Pirtobrutinib
22. Daily hassles and depressive symptoms among COVID-19 home quarantined Chinese university students: The moderating effects of negative cognitive styles.
23. Irrelevant emotional distractor faces and attentional capture by individuals with cognitive vulnerability to depression.
24. Decision-making approach in charging mode for electric vehicle based on cumulative prospect theory.
25. Full-wave analysis of non-radiative wireless power transmission system in half space.
26. Trends in three malnutrition factors in the global burden of disease: iodine deficiency, vitamin A deficiency, and protein-energy malnutrition (1990-2019).
27. Potential effects of specific gut microbiota on periodontal disease: a two-sample bidirectional Mendelian randomization study.
28. The Prostate Stromal Transcriptome in Aggressive and Lethal Prostate Cancer.
29. Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer.
30. Antitumor effects of baicalin on ovarian cancer cells through induction of cell apoptosis and inhibition of cell migration in vitro.
31. Decomposing a Chunk into Its Elements and Reorganizing Them As a New Chunk: The Two Different Sub-processes Underlying Insightful Chunk Decomposition.
32. Cytotoxic and chemosensitization effects of Scutellarin from traditional Chinese herb Scutellaria altissima L. in human prostate cancer cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.